| abstract |
The invention relates to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein A, R 1 , R 2 , R 3 , n and m are as described in the specification, useful in the treatment of n na disease or condition mediated through glucokinase (GLK), such as type 2 diabetes, The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase. |